Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NBIX - Neurocrine Biosciences Non-GAAP EPS of $1.08 misses by $0.04 revenue of $387.9M beats by $11.15M

NBIX - Neurocrine Biosciences Non-GAAP EPS of $1.08 misses by $0.04 revenue of $387.9M beats by $11.15M

Neurocrine Biosciences Inc.
  • Neurocrine Biosciences press release ( NASDAQ: NBIX ): Q3 Non-GAAP EPS of $1.08 misses by $0.04 .
  • Revenue of $387.9M (+31.0% Y/Y) beats by $11.15M .

  • INGREZZA ® (valbenazine) Third Quarter Net Product Sales of $376 Million

  • INGREZZA ® (valbenazine) 2022 Net Product Sales Guidance Raised to $1.4 - $1.425 Billion

  • Supplemental New Drug Application (sNDA) of Valbenazine For the Treatment of Chorea in Patients with Huntington Disease Submitted to the U.S. Food and Drug Administration

For further details see:

Neurocrine Biosciences Non-GAAP EPS of $1.08 misses by $0.04, revenue of $387.9M beats by $11.15M
Stock Information
Company Name: Neurocrine Biosciences Inc.
Stock Symbol: NBIX
Market: NASDAQ
Website: neurocrine.com
Menu
NBIX NBIX Quote NBIX Short NBIX News NBIX Articles NBIX Message Board
Get NBIX Alerts

News, Short Squeeze, Breakout and More Instantly...